Skip to main content
AMCP 2025 Main banner

Keynote

(K3) Specialty Pharmaceuticals in Development

Thursday, April 3, 2025
10:15 AM - 11:30 AM CST
Location: Grandballroom B
CPE
ACPE UAN:0233-0000-25-026-L01-P | Contact Hours: 1.25 | Activity Type: Knowledge-based
Specialty pharmaceuticals represent a rapidly expanding and incredibly diverse subset of prescription drugs. While many specialty pharmaceuticals are often associated with great therapeutic promise, the cost and complexity of these products pose unique challenges for healthcare providers, payers, and policymakers. It has never been more important for managed care professionals to stay ahead in this evolving treatment landscape.

Join this session to learn more about recent specialty approvals, emerging specialty products with potential for near-term approval, and trends within this area of drug development.

Learning Objectives:

At the completion of this activity, participants should be able to:
  1. Recognize recently approved specialty medications.
  2. List conditions with potential to see novel specialty medications gain FDA approval in the near-term.
  3. Describe the mechanism of action and potential place in therapy for new and emerging specialty medications.